Screener
Sarepta Therapeutics, Inc. SRPT Gain (loss) on disposal of assets
Gain (loss) on disposal of assets at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnInvestments.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|
| Non-cash interest expense | 19,006 | 2,602 |
| Non‑cash inventory write‑downs for obsolescence | 11,599 | — |
| Reduction in the carrying amounts of the right of use assets | 6,322 | 7,956 |
| Loss on strategic investments | 2,160 | 54,007 |
| Accretion of investment discount, net | (1,435) | (3,778) |
| Other | (1,298) | 701 |
| Changes in operating assets and liabilities, net: | ||
| Decrease in accounts receivable | 21,409 | 74,693 |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s gain (loss) on disposal of assets?
- Sarepta Therapeutics, Inc. (SRPT) reported gain (loss) on disposal of assets of -$448K in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s gain (loss) on disposal of assets changed year-over-year?
- Sarepta Therapeutics, Inc.'s gain (loss) on disposal of assets decreased by 101.2% year-over-year, from $36.72M to -$448K.
- What does gain (loss) on disposal of assets mean?
- Gains or losses recognized on the disposal of businesses, property, equipment, investments, or other assets at prices above or below their carrying value.
Ask your AI about Sarepta Therapeutics, Inc.'s gain (loss) on disposal of assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude